S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

Concord Medical Services (CCM) Stock Forecast, Price & News

-0.11 (-7.19%)
(As of 05/20/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
656 shs
Average Volume
6,890 shs
Market Capitalization
$61.66 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive CCM News and Ratings via Email

Sign-up to receive the latest news and ratings for Concord Medical Services and its competitors with MarketBeat's FREE daily newsletter.

Concord Medical Services logo

About Concord Medical Services

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners and emission computed tomograms scanners for diagnostic imaging, electroencephalography for the diagnosis of epilepsy, and ultrasound therapy. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2020, it operated a network of 27 cooperative centers based in 20 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.


Concord Medical Files 2020 Annual Report on Form 20-F
Concord Medical Services Holdings Limited (CCM)
See More Headlines

Industry, Sector and Symbol

Offices & clinics of medical doctors
Year Founded

Sales & Book Value

Annual Sales
$76.21 million
Book Value
($3.39) per share


Pretax Margin




Free Float
Market Cap
$61.66 million
Not Optionable

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

1.19 out of 5 stars

Medical Sector

1182nd out of 1,416 stocks

Offices & Clinics Of Medical Doctors Industry

9th out of 13 stocks

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Concord Medical Services (NYSE:CCM) Frequently Asked Questions

When is Concord Medical Services' next earnings date?

Concord Medical Services is scheduled to release its next quarterly earnings announcement on Friday, October 21st 2022.
View our earnings forecast for Concord Medical Services

How were Concord Medical Services' earnings last quarter?

Concord Medical Services Holdings Limited (NYSE:CCM) posted its quarterly earnings results on Wednesday, August, 24th. The company reported ($0.06) earnings per share for the quarter, missing analysts' consensus estimates of $0.21 by $0.27. The company earned $18.93 million during the quarter.
View Concord Medical Services' earnings history

Who are Concord Medical Services' key executives?
Concord Medical Services' management team includes the following people:
  • Dr. Jianyu Yang, Chairman & CEO (Age 51)
  • Mr. Yaw Kong Yap, CFO & Pres (Age 58)
  • Ms. Xiao Fu, Chief Operating Officer (Age 55)
  • Dr. Matthew D. Callister, Chief Medical Officer (Age 52)
  • Ms. Xun Liu, Financial Controller
What other stocks do shareholders of Concord Medical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Concord Medical Services investors own include The Carlyle Group (CG), (HCLP) (HCLP), Fibrocell Science (FCSC), Gilead Sciences (GILD), Laurentian Bank of Canada (LB), Altria Group (MO), Domtar (UFS), Arbutus Biopharma (ABUS), Franklin Resources (BEN) and Biocept (BIOC).

What is Concord Medical Services' stock symbol?

Concord Medical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "CCM."

Who are Concord Medical Services' major shareholders?

Concord Medical Services' stock is owned by many different retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (0.33%) and Concourse Financial Group Securities Inc. (0.00%).

Which institutional investors are selling Concord Medical Services stock?

CCM stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.

How do I buy shares of Concord Medical Services?

Shares of CCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Concord Medical Services' stock price today?

One share of CCM stock can currently be purchased for approximately $1.42.

How much money does Concord Medical Services make?

Concord Medical Services has a market capitalization of $61.66 million and generates $76.21 million in revenue each year.

How many employees does Concord Medical Services have?

Concord Medical Services employs 851 workers across the globe.

What is Concord Medical Services' official website?

The official website for Concord Medical Services is www.concordmedical.com.

How can I contact Concord Medical Services?

Concord Medical Services' mailing address is 18/F TOWER A GLOBAL TRADE CENTER 36 NORTH THIRD RING ROAD, BEIJING F4, 100013. The company can be reached via phone at 861059036688, via email at [email protected], or via fax at 86-10-5957-5252.

This page was last updated on 5/21/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.